The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Building Better Strategies to Manage Hematologic Malignancies and Disorders - Clinical Controversies and Opportunities to Optimize Outcomes


This presentation was selected by the American Society of Clinical Oncology® as an independent educational activity held in conjunction with an ASCO meeting. This presentation is not sponsored or endorsed by ASCO.

Building Better Strategies to Manage Hematologic Malignancies and Disorders - Clinical Controversies and Opportunities to Optimize Outcomes

Accept no Substitute: CR is the Only Viable Endpoint
Speaker: Ian W Flinn

Durable Remission and Quality of Life Measures are Equally as Meaningful
Speaker: P. Bergsagel

Improving Outcomes in Multiple Myeloma: Selection of the Optimal First-Line Therapy
Speaker: Antonio P Palumbo

CLL: Novel Treatment Options to Improve Patient Outcomes
Speaker: Asher Alban Akmal Chanan-Khan

Relapsed Diffuse Large B-Cell Lymphoma
Speaker: Thomas E Witzig

Where Do We Go From Here? Options for Patients with MDS
Speaker: Allen S. Yang

Maintenance Therapy: A Viable Option for Hematologic Malignancies?
Speaker: Susan Mary O'Brien





 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.